Hantz Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Hantz Financial Services's EW Position: Q1 2026 in Review
Hantz Financial Services increased its Edwards Lifesciences (EW) stake by 262% in Q1 2026, buying an estimated $82.8K and bringing the position to 1,387 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.
Hantz Financial Services first reported a position in EW in Q4 2020 and has held it in 22 quarters since. The position peaked at $577K in Q3 2023. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Hantz Financial Services held 1,387 shares of Edwards Lifesciences worth $111K as of Q1 2026.
- Hantz Financial Services bought 1,004 Edwards Lifesciences shares in Q1 2026, an estimated $82.8K.
- Edwards Lifesciences made up ﹤0.01% of Hantz Financial Services's portfolio in Q1 2026, its #1255 holding.
- Hantz Financial Services first reported a position in Edwards Lifesciences in Q4 2020 and has held it in 22 quarters since.
- Hantz Financial Services's Edwards Lifesciences position peaked at $577K in Q3 2023.
- 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.